{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:08:30Z","timestamp":1772989710966,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13368-2","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T13:56:45Z","timestamp":1736258205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Androgen receptor overexpression by immunohistochemistry in malignant salivary gland tumors in Tanzania"],"prefix":"10.1186","volume":"25","author":[{"given":"Subira","family":"Matiku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Murenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eulade","family":"Rugengamanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Liwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idd","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Orgenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick P.","family":"Magorosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Mwakigonja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edda","family":"Vuhahula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"issue":"1","key":"13368_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12105-022-01420-1","volume":"16","author":"A Sk\u00e1lov\u00e1","year":"2022","unstructured":"Sk\u00e1lov\u00e1 A, Hyrcza MD, Leivo I. Update from the 5th Edition of the World Health Organization Classification of Head and Neck tumors: salivary glands. Head Neck Pathol. 2022;16(1):40\u201353.","journal-title":"Head Neck Pathol"},{"issue":"4","key":"13368_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.oraloncology.2007.05.010","volume":"44","author":"AV Jones","year":"2008","unstructured":"Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44(4):407\u201317.","journal-title":"Oral Oncol"},{"issue":"11","key":"13368_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.joms.2006.11.025","volume":"65","author":"MH Ansari","year":"2007","unstructured":"Ansari MH. Salivary gland tumors in an Iranian Population: a retrospective study of 130 cases. J Oral Maxillofac Surg. 2007;65(11):2187\u201394.","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"13368_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","volume":"74","author":"M Guzzo","year":"2010","unstructured":"Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74(2):134\u201348.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"04","key":"13368_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/2278-330x.119886","volume":"02","author":"RS Laishram","year":"2013","unstructured":"Laishram RS, AK K, Pukhrambam GD, Laishram S, Debnath K. Pattern of salivary gland tumors in Manipur, India: a 10 year study. South Asian J Cancer. 2013;02(04):250\u20133.","journal-title":"South Asian J Cancer"},{"issue":"3","key":"13368_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3\u20134","key":"13368_CR7","first-page":"139","volume":"23","author":"H Helen Lin","year":"2018","unstructured":"Helen Lin H, Limesand KH, Ann DK. Current state of knowledge on salivary gland cancers. Crit Rev Oncog. 2018;23(3\u20134):139\u201351.","journal-title":"Crit Rev Oncog"},{"key":"13368_CR8","doi-asserted-by":"crossref","unstructured":"Masanja MI, Kalyanyama BM, Simon M. EN. SALIVARY GLAND TUMOURS IN TANZANIA. Vol. 80, EAST AFRICAN MEDICAL JOURNAL 429 East African Medical Journal. 2003.","DOI":"10.4314\/eamj.v80i8.8736"},{"key":"13368_CR9","doi-asserted-by":"crossref","unstructured":"Gilyoma JM, Rambau PF, Masalu N, Kayange NM, Chalya PL. Head and neck cancers: a clinico-pathological profile and management challenges in a resource-limited setting. BMC Res Notes. 2015;8(1).","DOI":"10.1186\/s13104-015-1773-9"},{"key":"13368_CR10","doi-asserted-by":"crossref","unstructured":"Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D et al. Management of Salivary Gland Malignancy: ASCO Guideline [Internet]. Vol. 39, J Clin Oncol. 2021. Available from: www.asco.org\/head-neck-cancer-guidelines","DOI":"10.1200\/JCO.21.00449"},{"issue":"33","key":"13368_CR11","doi-asserted-by":"publisher","first-page":"E985","DOI":"10.1503\/cmaj.180286","volume":"190","author":"A Elkrief","year":"2018","unstructured":"Elkrief A, Saleh R. Androgen deprivation therapy for metastatic salivary gland cancer. Can Med Assoc J. 2018;190(33):E985\u20137.","journal-title":"Can Med Assoc J"},{"key":"13368_CR12","doi-asserted-by":"crossref","unstructured":"Chintakuntlawar AV, Okuno SH, Price KA. Systemic therapy for recurrent or metastatic salivary gland malignancies. Cancers Head Neck. 2016;1(1).","DOI":"10.1186\/s41199-016-0011-z"},{"key":"13368_CR13","unstructured":"Tanzania. United Republic of."},{"issue":"3","key":"13368_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hed.25035","volume":"40","author":"E Boon","year":"2018","unstructured":"Boon E, van Boxtel W, Buter J, Baatenburg de Jong RJ, van Es RJJ, Bel M, et al. Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in the Netherlands. Head Neck. 2018;40(3):605\u201313.","journal-title":"Head Neck"},{"issue":"11","key":"13368_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/COC.0000000000000429","volume":"41","author":"RB Cohen","year":"2018","unstructured":"Cohen RB, Delord JP, Doi T, Piha-Paul SA, Liu SV, Gilbert J, et al. Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma. Am J Clin Oncol. 2018;41(11):1083\u20138.","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"13368_CR16","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/bjc.2013.468","volume":"109","author":"E Hitre","year":"2013","unstructured":"Hitre E, Budai B, Tak\u00e1csi-Nagy Z, Rubovszky G, T\u00f3th E, Remen\u00e1r \u00c9, et al. Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial. Br J Cancer. 2013;109(5):1117\u201322.","journal-title":"Br J Cancer"},{"issue":"Supplement 2","key":"13368_CR17","doi-asserted-by":"publisher","first-page":"s192","DOI":"10.1200\/jgo.18.79201","volume":"4","author":"A Adatia","year":"2018","unstructured":"Adatia A. Clinicopathological features and treatment outcomes in parotid malignancies at Ocean Road Cancer Institute, Dar-es-Salaam, Tanzania. J Glob Oncol. 2018;4(Supplement 2):s192\u2013192.","journal-title":"J Glob Oncol"},{"issue":"3","key":"13368_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","volume":"37","author":"K Fujita","year":"2019","unstructured":"Fujita K, Nonomura N. Role of androgen receptor in prostate Cancer: a review. World J Mens Health. 2019;37(3):288.","journal-title":"World J Mens Health"},{"issue":"2","key":"13368_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.18632\/oncotarget.2831","volume":"6","author":"J Munoz","year":"2015","unstructured":"Munoz J, Wheler JJ, Kurzrock R. Androgen receptors beyond prostate cancer: an old marker as a new target. Oncotarget. 2015;6(2):592\u2013603.","journal-title":"Oncotarget"},{"issue":"8","key":"13368_CR20","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/annonc\/mdg331","volume":"14","author":"LD Locati","year":"2003","unstructured":"Locati LD, Quattrone P, Bossi P, Marchian\u00f2 AV, Cant\u00f9 G, Licitra L. A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Ann Oncol. 2003;14(8):1327\u20138.","journal-title":"Ann Oncol"},{"key":"13368_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2018.12.035","volume":"110","author":"W van Boxtel","year":"2019","unstructured":"van Boxtel W, Locati LD, van Engen-van Grunsven ACH, Bergamini C, Jonker MA, Fiets E, et al. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor\u2013positive salivary duct carcinoma. Eur J Cancer. 2019;110:62\u201370.","journal-title":"Eur J Cancer"},{"key":"13368_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.humpath.2019.08.007","volume":"93","author":"B Xu","year":"2019","unstructured":"Xu B, Dogan S, Haroon Al Rasheed MR, Ghossein R, Katabi N. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance. Hum Pathol. 2019;93:30\u20136.","journal-title":"Hum Pathol"},{"issue":"6","key":"13368_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1309\/RVTP1G0Q727WJUQD","volume":"119","author":"SM Nasser","year":"2003","unstructured":"Nasser SM, Faquin WC, Dayal Y. Expression of Androgen, Estrogen, and progesterone receptors in salivary gland tumors. Am J Clin Pathol. 2003;119(6):801\u20136.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"13368_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.oooo.2012.04.008","volume":"114","author":"FP Fonseca","year":"2012","unstructured":"Fonseca FP, de Vasconcelos Carvalho M, de Almeida OP, Rangel ALCA, Takizawa MCH, Bueno AG, et al. Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):230\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"13368_CR25","first-page":"98","volume":"29","author":"BF Adeyemi","year":"2010","unstructured":"Adeyemi BF, Ogun GO, Akang EE. Retrospective analysis of intra-oral salivary gland tumours in Ibadan, Nigeria. West Afr J Med. 2010;29(2):98\u2013103.","journal-title":"West Afr J Med"},{"key":"13368_CR26","unstructured":"Vuhahula EAM. Salivary gland tumors in Uganda: clinical pathological study. Volume 4. African Health Sciences; 2004."},{"key":"13368_CR27","doi-asserted-by":"crossref","unstructured":"Sando Z, Fokouo JVF, Mebada AO, Djomou F, Ndjolo A, Oyono JLE. Epidemiological and histopathological patterns of salivary gland tumors in Cameroon. Pan Afr Med J. 2016;23.","DOI":"10.11604\/pamj.2016.23.66.5105"},{"issue":"1","key":"13368_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/odi.12956","volume":"25","author":"OG Omitola","year":"2019","unstructured":"Omitola OG, Soyele OO, Butali A, Akinshipo AO, Okoh D, Sigbeku O, et al. Descriptive epidemiology of salivary gland neoplasms in Nigeria: an AOPRC multicenter tertiary hospital study. Oral Dis. 2019;25(1):142\u20139.","journal-title":"Oral Dis"},{"key":"13368_CR29","doi-asserted-by":"crossref","unstructured":"Speight PM, Barrett AW. Salivary gland tumours: diagnostic challenges and an update on the latest WHO classification. Vol. 26, diagnostic histopathology. Elsevier Ltd; 2020. pp. 147\u201358.","DOI":"10.1016\/j.mpdhp.2020.01.001"},{"issue":"5","key":"13368_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/jcm8050566","volume":"8","author":"K Sentani","year":"2019","unstructured":"Sentani K, Ogawa I, Ozasa K, Sadakane A, Utada M, Tsuya T, et al. Characteristics of 5015 salivary gland neoplasms registered in the Hiroshima Tumor Tissue Registry over a period of 39 years. J Clin Med. 2019;8(5):566.","journal-title":"J Clin Med"},{"key":"13368_CR31","doi-asserted-by":"crossref","unstructured":"Mengi E. Salivary gland tumors: a 15-year experience of a univers\u0131ty hospital in Turkey. North Clin Istanb. 2020.","DOI":"10.14744\/nci.2020.57767"},{"issue":"9","key":"13368_CR32","first-page":"525","volume":"69","author":"JF Onyango","year":"1992","unstructured":"Onyango JF, Awange DO, Muthamia JM, Muga BI. Salivary gland tumours in Kenya. East Afr Med J. 1992;69(9):525\u201330.","journal-title":"East Afr Med J"},{"issue":"123","key":"13368_CR33","first-page":"17","volume":"31","author":"OM Gbotolorun","year":"2008","unstructured":"Gbotolorun OM, Arotiba GT, Effiom OA, Omitola OG. Minor salivary gland tumours in a Nigerian hospital: a retrospective review of 146 cases. Odontostomatol Trop. 2008;31(123):17\u201323.","journal-title":"Odontostomatol Trop"},{"key":"13368_CR34","doi-asserted-by":"crossref","unstructured":"Hill AG. Major salivary gland tumors in a rural Kenyan Hospital. East Afr Med J. 2002;79(1).","DOI":"10.4314\/eamj.v79i1.8917"},{"key":"13368_CR35","volume-title":"Androgen receptor signaling in salivary gland cancer","author":"MG Dalin","year":"2017","unstructured":"Dalin MG, Watson PA, Ho AL, Morris LGT. Androgen receptor signaling in salivary gland cancer. Volume 9. Cancers: MDPI AG; 2017."},{"issue":"9","key":"13368_CR36","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1002\/hed.25857","volume":"41","author":"M Szewczyk","year":"2019","unstructured":"Szewczyk M, Marsza\u0142ek A, Sygut J, Golusi\u0144ski P, Golusi\u0144ski W. Prognostic markers in salivary gland cancer and their impact on survival. Head Neck. 2019;41(9):3338\u201347.","journal-title":"Head Neck"},{"issue":"4","key":"13368_CR37","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ijc.31353","volume":"143","author":"E Boon","year":"2018","unstructured":"Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, et al. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from the Netherlands. Int J Cancer. 2018;143(4):758\u201366.","journal-title":"Int J Cancer"},{"issue":"9","key":"13368_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/archotol.127.9.1075","volume":"127","author":"CY Fan","year":"2001","unstructured":"Fan CY, Melhem MF, Hosal AS, Grandis JR, Barnes EL. Expression of androgen receptor, Epidermal Growth Factor Receptor, and transforming growth factor \u03b1 in Salivary Duct Carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(9):1075.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"13368_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","volume":"39","author":"L Williams","year":"2015","unstructured":"Williams L, Thompson LDR, Seethala RR, Weinreb I, Assaad AM, Tuluc M, et al. Salivary Duct Carcinoma. Am J Surg Pathol. 2015;39(5):705\u201313.","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"13368_CR40","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.3390\/ijms22136771","volume":"22","author":"MT Meyer","year":"2021","unstructured":"Meyer MT, Watermann C, Dreyer T, Erg\u00fcn S, Karnati S. 2021 update on diagnostic markers and translocation in salivary gland tumors. Int J Mol Sci. 2021;22(13):6771.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"13368_CR41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/jop.12741","volume":"47","author":"CC Yeoh","year":"2018","unstructured":"Yeoh CC, Dabab N, Rigby E, Chhikara R, Akaev I, Gomez RS, et al. Androgen receptor in salivary gland carcinoma: a review of an old marker as a possible new target. J Oral Pathol Med. 2018;47(7):691\u20135.","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"13368_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ijms19020399","volume":"19","author":"G Aquino","year":"2018","unstructured":"Aquino G, Collina F, Sabatino R, Cerrone M, Longo F, Ionna F, et al. Sex hormone receptors in Benign and malignant salivary gland tumors: prognostic and predictive role. Int J Mol Sci. 2018;19(2):399.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"13368_CR43","doi-asserted-by":"publisher","first-page":"2473974X1771563","DOI":"10.1177\/2473974X17715633","volume":"1","author":"S Rahimi","year":"2017","unstructured":"Rahimi S, Bradley KL, Akaev I, Marani C, Yeoh CC, Brennan PA. Androgen receptor expression in primary nonsquamous cell rare-variant carcinomas of the Head and Neck. OTO Open. 2017;1(2):2473974X1771563.","journal-title":"OTO Open"},{"issue":"3","key":"13368_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1066896914565024","volume":"23","author":"K Ishibashi","year":"2015","unstructured":"Ishibashi K, Ito Y, Fujii K, Masaki A, Beppu S, Kawakita D, et al. Androgen receptor\u2013positive Mucoepidermoid Carcinoma. Int J Surg Pathol. 2015;23(3):243\u20137.","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"13368_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1590\/S1806-83242009000400008","volume":"23","author":"FA Ito","year":"2009","unstructured":"Ito FA, Ito K, Coletta R, Della, Vargas PA, Lopes MA. Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors. Braz Oral Res. 2009;23(4):393\u20138.","journal-title":"Braz Oral Res"},{"issue":"5","key":"13368_CR46","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hed.23940","volume":"38","author":"LD Locati","year":"2016","unstructured":"Locati LD, Perrone F, Cortelazzi B, Lo Vullo S, Bossi P, Dagrada G, et al. Clinical activity of androgen deprivation therapy in patients with metastatic\/relapsed androgen receptor-positive salivary gland cancers. Head Neck. 2016;38(5):724\u201331.","journal-title":"Head Neck"},{"key":"13368_CR47","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.2147\/OTT.S304900","volume":"14","author":"Y You","year":"2021","unstructured":"You Y, Wang P, Wan X, Xu L, Gong Y, Zhang W. Androgen Deprivation Therapy for patients with androgen-receptor-positive metastatic salivary Duct Carcinoma: a Case Report and Review of the literature. Onco Targets Ther. 2021;14:3481\u20136.","journal-title":"Onco Targets Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13368-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:03:59Z","timestamp":1736301839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13368"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13368-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Muhimbili University of Health and Allied Science\u2019s institutional review board and informed consent was waived given that no contact was made with participants with the use of medical records and archived tissue blocks and slides.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}